April 2022 FDA Recall Drug by Remedyrepack Inc.
D-0788-2022 - CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on April 6, 2022 for the product Drug. The FDA reported the reason for recall as cgmp deviations- azido impurity levels observed to be above acceptable limits.. The product was distributed in Product was distributed to customers in AK and PA. and the recall is currently terminated.

Recall Number: D-0788-2022

Reason for Recall
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Initiated
04-06-2022
Reported
05-04-2022
Quantity
433/30 count blister cards, 33/60 count blister cards

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Product was distributed to customers in AK and PA.
Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only, MFG by: Lupin Pharma, Baltimore, MD 21202.

Batch or Lot Expiration Information

Lot# B1467803-120621, exp. date 06/30/2022
Lot# J0585793-121721, exp. date 12/31/2022